Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Evolus Q1 2024 Adj EPS $(0.08) Beats $(0.10) Estimate, Sales $59.333M Beat $57.321M Estimate

Author: Benzinga Newsdesk | May 07, 2024 04:39pm
Evolus (NASDAQ:EOLS) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.10) by 20 percent. This is a 46.67 percent increase over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $59.333 million which beat the analyst consensus estimate of $57.321 million by 3.51 percent. This is a 42.21 percent increase over sales of $41.721 million the same period last year.

Posted In: EOLS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist